Uncategorized

Top 10 Crucial Questions to Ask Your Pharmacist Before Taking Medicine

Top 10 Crucial Questions to Ask Your Pharmacist Before Taking Medicine   Before taking any medication, it’s important to engage with your healthcare provider, especially your pharmacist, to ensure that you have a comprehensive understanding of the medication. Asking the right questions can help you make informed decisions about your health and avoid potential risks […]

Top 10 Crucial Questions to Ask Your Pharmacist Before Taking Medicine Read More »

What is R-CHOP?

R-CHOP is a chemotherapy regimen commonly used in the treatment of non-Hodgkin lymphoma (NHL), specifically the most common type called diffuse large B-cell lymphoma (DLBCL). R-CHOP stands for: R – Rituximab: A monoclonal antibody that targets a protein called CD20 found on the surface of B-cells, which helps to destroy cancerous B-cells. C – Cyclophosphamide:

What is R-CHOP? Read More »

Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira®

Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira® Medical advancements have revolutionized the treatment options for various diseases and conditions. In recent years, biosimilars have gained significant attention as cost-effective alternatives to biologic medications. One such biosimilar is Cyltezo, which is an interchangeable biosimilar to Humira®, a commonly used medication for

Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira® Read More »

Regeneron’s Pozelimab-BBFG Receives FDA Approval as First Treatment for CHAPLE Disease

The drug Pozelimab can cause life-threatening meningococcal infections, so it is important to get a meningococcal vaccine at least 2 weeks before starting the drug.

It is used to treat a health problem called CD55-deficient protein-losing enteropathy (CHAPLE disease).

Regeneron’s Pozelimab-BBFG Receives FDA Approval as First Treatment for CHAPLE Disease Read More »